Generally speaking, it is very difficult to use Kampo medicine for acute diseases, such as injury, surgical treatment and emergency medicine instead of modern medicine. Because Kampo medicine can usually use by oral in Japan, it is hard to use Kampo for treatment of the unconscious patients or patients with nausea for example.
Recently there are some reports which showed the better treatment of acute diseases by Kampo medicine alone, or by modern medicine with Kampo medicine than modern medicine alone. In this symposium, speakers will show the newest therapies and new concepts of the management for the acute diseases by Kampo medicine. The organizers in this symposium hope that the audience can know the possibility of treatment on acute disease by Kampo medicine. Because Shanghanlun, a textbook of Kampo medicine, was originally written about acute febrile illnesses, acute respiratory tract symptoms are a very good indication for Kampo medicine. Recent evidence reports about Kampo formulations indicated for common cold, rhinitis, bronchitis, bronchial asthma and throat discomfort were reviewed. Japanese traditional standard for administration of these formulations were also discussed. A patient with common cold responded to keishimaokakuhanto, a patient with pollen allergy responded to eppikajutsuto, a patient with bronchitis responded to bakumondoto and a patient with bronchial asthma responded to makyokansekito were presented.
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Acute gastroenteritis, considered to have been caused by norovirus, went around in the medical care zone of our hospital in the winter of 2005. At that time, we successfully treated many cases with ogonto. We also prescribed ogonto to the elderly patients with acute gastroenteritis prevailing in a senior care facility. Ogonto was again found to be effective.
We considered that ogonto was useful as a therapeutic medication for acute gastroenteritis.
We have been treating patients in an elder senior care facility with mainly Kampo medicine for many years. We chose Kampo formulations according to a Kampo treatment manual, and started Kampo treatment for pyrexia from the early stage.
Here we reported the results of this treatment for cases suffering from pyrexia in this facility from June, 2004 to May, 2005. About 90% of the pyrexia cases were cured only by treatment in this facility, and about 80% of cases recovered with Kampo formulations only. Cases for which other drugs were used together with Kampo formulations, could not take Kampo formulations, or did not show lower fever levels within two days after Kampo formulation administration were grave, and most needed hospitalization. The most frequently used formulation in this study was maoto. We consider that Kampo medicine will be effective in the primary care of elderly people with pyrexia. Cerebral infarction is quite a common disease among elder people. Although vital prognosis has been developed, quality of life (QOL) of the patients has not always been satisfied.
We have experienced 14 patients with acute cerebral infarction who treated with Kampo therapy combined by low dose of argatroban. Goreisan was administered to all patients and, furthermore we used saikokeishito, san'oshasinto or orengedokuto by the diagnosis of abdominal examination. Then, their clinical prognosis were compared with that of the results of Japan Standard Stroke Registry Study (JSSRS). These Kampo medicine combination group showed short hospitalization, though high age, and improved Japan Stroke Scale at the time of the discharge. Application of Kampo therapy to acute cerebral infarction may be useful to especially elder people. We discussed the relation of retained fluid and cerebral infarction.
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SIRS
To evaluate the effect of preoperative administration of hochuekkito, a Japanese herbal medicine, on postoperative systeminc inflammatory response syndrome (SIRS), we studied the effect of hochuekkito on the patients undergoing gastrectomy or colectomy in the prospective, randomized, multicenter clinical trial. Fortyeight stomach (gastric)/colon cancer patients undergoing gastrectomy or colectomy were randomized into the two groups ; the group receiving 7.5 g/day of hochuekkito before surgery (n 22) and the unprescribed control group (n 26). The value of soluble IL-2 receptor right before the surgery, the concentration of cortisol on the 1 st day after surgery, and body temperature during the study were significantly controlled in the hochuekkito group compared to those in the control group. These results suggested that preoperative administration of hochuekkito might ameliorate excessive postoperative inflammatory responses, resulting in decreasing postoperative complications.
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